ProText Mobility, Inc.

TXTM

US74371E2046

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 03:59:54 2024-04-26 pm EDT			5-day change	1st Jan Change
0.0023 ^USD	+27.78%		+27.78%	+35.29%

2022	Protext Mobility, Inc and RSAMMDA LLC Provides the Shareholder Update	CI
2021	ProText Mobility, Inc. Provides Updates on Research Conducted At A Licensed Facility	CI

ProText Mobility, Inc. has Changed its Name to Protext Pharma, Inc

May 23, 2017 at 12:00 am EDT

On May 23, 2017, ProText Mobility, Inc. changed its name to Protext Pharma, Inc.

Latest news about ProText Mobility, Inc.

Protext Mobility, Inc and RSAMMDA LLC Provides the Shareholder Update	22-11-01	CI
ProText Mobility, Inc. Provides Updates on Research Conducted At A Licensed Facility	21-10-29	CI
ProText Mobility, Inc. cancelled the acquisition of 60% in Growprocess, Inc.	19-01-18	CI
ProText Mobility, Inc. signed a letter of intent to acquire 60% in Growprocess, Inc.	18-01-18	CI
ProText Mobility, Inc. has Changed its Name to Protext Pharma, Inc	17-05-23	CI
Protext Mobility, Inc. to Conduct Human Clinical Trial with Its Product Phytofare Catechin Complex	17-05-04	CI
ProText Mobility, Inc. acquired Cannabis Biosciences Inc. from Plandaí Biotechnology, Inc. for $0.12 million.	17-03-26	CI
Protext Mobility, Inc. Engages in the Development of Pharmaceutical Applications for the Highly Bioavailable Phytofare®	17-03-07	CI
Plandai SA completed the acquisition of ProText Mobility, Inc. in a reverse merger transaction.	16-12-30	CI
Plandai SA agreed to acquire ProText Mobility, Inc. in a reverse merger transaction.	16-12-22	CI

Protext Mobility, Inc. is a biotech company, which is engaged in the development of a cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes and technologies. The Company is engaged in the research, testing and development of highly bioavailable botanical products all-natural ingredients formulated for nutraceutical and pharmaceutical applications through the use of proprietary live plant extraction technology. The Companyâs subsidiaries include Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc.

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
PROTEXT MOBILITY, INC.	+35.29%	20.22M
VERTEX PHARMACEUTICALS INCORPORATED	-2.31%	103B
REGENERON PHARMACEUTICALS, INC.	+0.56%	95.28B
ARGENX SE	+1.69%	22.15B
BIONTECH SE	-17.37%	21.02B
GENMAB A/S	-9.30%	18.15B
WUXI APPTEC CO., LTD.	-41.01%	16.74B
BEIGENE, LTD.	-14.85%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+3.21%	13.68B
SAREPTA THERAPEUTICS, INC.	+33.54%	12.17B

Bio Therapeutic Drugs